Alfonso Gúrpide
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Molecular Biology
- Cancer Research top 5%
- Co-authors
- José Luis Perez‐GraciaIgnacio MeleroSalvador Martín‐AlgarraJosé M. López-PicazoMaría E. Rodríguez-RuizMiguel F. SanmamedÁlvaro GonzálezKurt A. Schalper
- Topics
- Lung Cancer Treatments and Mutations (23 papers)Lung Cancer Research Studies (16 papers)Cancer Immunotherapy and Biomarkers (12 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Alfonso Gúrpide
74 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 1.0k
- Immunology 782
- Molecular Biology 511
- Cancer Research 392
Countries citing papers authored by Alfonso Gúrpide
This map shows the geographic impact of Alfonso Gúrpide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Gúrpide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Gúrpide more than expected).
Fields of papers citing papers by Alfonso Gúrpide
This network shows the impact of papers produced by Alfonso Gúrpide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Gúrpide. The network helps show where Alfonso Gúrpide may publish in the future.
Co-authorship network of co-authors of Alfonso Gúrpide
This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Gúrpide. A scholar is included among the top collaborators of Alfonso Gúrpide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Gúrpide. Alfonso Gúrpide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 11 | |
| 4 | 8 | |
| 5 | 34 | |
| 6 | 34 | |
| 7 | 8 | |
| 8 | 52 | |
| 9 | 69 | |
| 10 | 13 | |
| 11 | 8 | |
| 12 | 39 | |
| 13 | 34 | |
| 14 | 247 | |
| 15 | 31 | |
| 16 | 45 | |
| 17 | 16 | |
| 18 | 7 | |
| 19 | 12 | |
| 20 | [HIV infection in an autonomous Spanish community (La Rioja). Features, trends and conclusions applicable to other regions]. | 1 |
About Alfonso Gúrpide
Alfonso Gúrpide is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 75 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (16 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (782 citations) and Genetics (379 citations). Alfonso Gúrpide has collaborated with scholars based in Spain, United States and France. Frequent co-authors include José Luis Perez‐Gracia, Ignacio Melero, Salvador Martín‐Algarra, José M. López-Picazo, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, Álvaro González, Kurt A. Schalper, Carlos Alfaro and Pedro Berraondo. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.